🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "targeted steps to deal with household expense challenges" in the upcoming Budget.

Speaking to the BBC, she stated that curbing price rises is a shared duty of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven developed nations this calendar year and next.

Possible Utility Bill Interventions

Sources suggest the administration could take action to reduce utility costs, for instance by cutting the current 5% level of VAT charged on energy supplies.

Another possibility is to cut some of the policy costs currently included in bills.

Budgetary Constraints and Expert Expectations

The administration will obtain the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for such measures.

The consensus from most economists is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to fulfill her self-imposed borrowing rules.

Earlier on Thursday, estimates indicated there was a £22bn shortfall for the Treasury chief to address, which is at the lower end of forecasts.

"It is a shared responsibility between the central bank and the government to bear down further on some of the sources of price increases," Reeves informed reporters in the US capital, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and International Issues

While a great deal of the focus has been on expected tax increases, the chancellor said the latest data from the OBR had not altered her pledge to campaign commitments not to raise tax levels on earnings tax, sales tax or social security contributions.

She attributed an "uncertain world" with growing international and trade concerns for the fiscal revenue measures, probably to be directed on those "most able to pay."

Global Economic Tensions

Commenting on concerns about the UK's trade ties with China she said: "Our national security invariably take priority."

Last week's statement by Chinese authorities to strengthen export controls on critical minerals and other resources that are crucial for advanced tech production led American leader Donald Trump to threaten an further 100% import tax on imports from the Asian country, raising the possibility of an all-out commercial conflict between the two economic giants.

The American finance chief labeled the Chinese decision "economic coercion" and "a international production control attempt."

Asked about accepting the US offer to participate in its dispute with China, Reeves said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "not to put up barriers and limit trade."

She said the move was "damaging for the world economy and creates additional headwinds."

"I believe there are areas where we must address Chinese policies, but there are also important chances to sell into China's economy, including banking sector and other sectors of the economic system. We've got to achieve that balance appropriate."

The chancellor also confirmed she was collaborating with international partners "regarding our own critical minerals approach, so that we are less reliant."

Health Service Drug Costs and Investment

Reeves also acknowledged that the price the National Health Service spends on pharmaceuticals could go up as a consequence of ongoing talks with the US government and its drugs companies, in exchange for lower tariffs and investment.

Some of the world's largest drug companies have said in recent statements that they are either pausing or scrapping investments in the United Kingdom, with several blaming the modest returns they are getting.

Recently, the Science Minister said the price the health service pays for drugs would must go up to halt companies and pharmaceutical investment leaving the United Kingdom.

The Chancellor told the BBC: "It has been observed because of the pricing regime, that drug testing, innovative medicines have not been provided in the UK in the manner that they are in other EU nations."

"We want to ensure that people getting treatment from the National Health Service are can receive the best life-saving treatments in the globe. And so we are reviewing these issues, and... aiming to attract increased funding into the UK."